Please sign in to follow a disease.
Thrombocytopenia
MONDO:0002049A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.
Also known as: platelet count decreased, thrombocytopenic disorder
266 clinical trials for this condition and its sub-types, 74 tagged with Thrombocytopenia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytopenia
-
Thrombocytopenic purpura 8 trials · 116 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types Sub-types →
-
Autoimmune thrombocytopenia 8 trials · 113 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Evans syndrome 19 trials
-
Inherited thrombocytopenia 2 trials · 29 incl. sub-types
21 sub-types
- Thrombocytopenia 1 9 trials
- Syndromic constitutional thrombocytopenia 0 trials · 8 incl. sub-types Sub-types →
- Congenital amegakaryocytic thrombocytopenia 4 trials · 6 incl. sub-types Sub-types →
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Alpha granule disease 0 trials Sub-types →
- Autosomal dominant macrothrombocytopenia 0 trials Sub-types →
- Congenital autosomal recessive small-platelet thrombocytopenia 0 trials
- Isolated delta-storage pool disease 0 trials
- Macrothrombocytopenia, isolated 0 trials Sub-types →
- Thrombocytopenia 10 0 trials
- Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0 trials
- Thrombocytopenia 12 with or without myopathy 0 trials
- Thrombocytopenia 13, syndromic 0 trials
- Thrombocytopenia 2 0 trials
- Thrombocytopenia 3 0 trials
- Thrombocytopenia 4 0 trials
- Thrombocytopenia 5 0 trials
- Thrombocytopenia 7 0 trials
- Thrombocytopenia 9 0 trials
- Thrombocytopenia, X-linked, with or without dyserythropoietic anemia 0 trials Sub-types →
- Thrombocytopenia, cyclic 0 trials
-
Acquired thrombocytopenia 11 trials · 24 incl. sub-types
1 sub-type
-
Neonatal thrombocytopenia 5 trials
1 sub-type
- Transient neonatal thrombocytopenia 0 trials
Most studied deeper sub-types
-
Can a Platelet-Boosting drug help control a rare bone marrow disorder?
Disease control OngoingResearchers are observing how well eltrombopag works in adults with hypocellular myelodysplastic neoplasms, a bone marrow condition that lowers blood cell counts. The study follows patients in Italy who receive eltrombopag alone or with immunosuppressive therapy as part of routin…
Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising prostate cancer trial pulled before it began
Disease control CancelledThis study was designed to test a radioactive drug (177Lu-PSMA-617) in men with advanced prostate cancer that has spread to the bone marrow and caused low blood cell counts. The goal was to see if the treatment was safe and how it affected the cancer. However, the study was withd…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo shows promise for rare blood disorder
Disease control OngoingThis study tests whether adding eltrombopag to standard immunosuppressive therapy can improve blood cell counts in people with untreated severe aplastic anemia. Participants receive horse-ATG and cyclosporine plus eltrombopag for up to 6 months. The goal is to see if this combina…
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Pill could help control Low-Risk bone marrow cancer
Disease control OngoingThis study tests an oral medication called azacitidine (ONUREG) for people with a low- or intermediate-risk form of myelodysplastic syndrome (MDS), a bone marrow disorder. About 230 participants will receive either the drug or a placebo, along with standard supportive care. The g…
Phase 2/3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Promising ITP drug trial pulled before it even started
Disease control CancelledThis study was designed to test the safety and tolerability of a new drug called HMPL-523 (sovleplenib) in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The trial was withdrawn before enrolling any pa…
Phase 1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 26, 2026 18:23 UTC
-
NIH opens screening study to find candidates for blood disorder research
Knowledge-focused By invitation onlyThis study screens up to 10,000 people with blood disorders or healthy volunteers to see if they can safely join other active research studies at the National Heart, Lung, and Blood Institute. Participants undergo clinical, imaging, and lab tests. If no suitable study is availabl…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
COVID vaccine clot study scrapped before start
Knowledge-focused CancelledThis study aimed to collect medical information from people who developed unusual blood clots within four weeks of receiving a COVID-19 vaccine. The goal was to better understand any possible link between the vaccine and these rare events. However, the study was withdrawn before …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC